antiviral drug
J&J’s dengue pill shows antiviral activity in human trial, could prevent millions of infections
Anika Sharma
Amidst Johnson & Johnson’s strategic restructuring in the infectious disease and vaccine divisions, one resilient contender has emerged. JNJ-1802, an ...
